CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-21 | Hunkapiller Michael Director | Option exercise | +152,474 | $2.27 | $346K | 1,050,689 |
| 2021-01-21 | Hunkapiller Michael Director | Option exercise | +56,237 | $6.14 | $345K | 1,106,926 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −29,049 | $35.44 | $1.0M | 1,077,877 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −113,472 | $36.39 | $4.1M | 964,405 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −61,834 | $37.18 | $2.3M | 902,571 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −700 | $38.06 | $27K | 901,871 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −3,656 | $39.09 | $143K | 898,215 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −23,817 | $36.30 | $865K | 874,398 |
| 2021-01-21 | Hunkapiller Michael Director | Sale | −25,993 | $37.13 | $965K | 848,405 |
| 2021-01-21 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −152,474 | 0 | ||
| 2021-01-21 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −56,237 | 443,763 | ||
| 2021-01-20 | Hunkapiller Michael Director | Option exercise | +215,026 | $2.27 | $488K | 1,113,241 |
| 2021-01-20 | Hunkapiller Michael Director | Sale | −141,199 | $38.79 | $5.5M | 972,042 |
| 2021-01-20 | Hunkapiller Michael Director | Sale | −43,846 | $39.35 | $1.7M | 928,196 |
| 2021-01-20 | Hunkapiller Michael Director | Sale | −24,032 | $40.69 | $978K | 904,164 |
| 2021-01-20 | Hunkapiller Michael Director | Sale | −5,949 | $41.41 | $246K | 898,215 |
| 2021-01-20 | Hunkapiller Michael Director | Option exercise · Stock Option (right to buy) | −215,026 | 152,474 | ||
| 2021-01-08 | Fromen Peter Chief Commercial Officer | Grant or award | +160,000 | 160,000 | ||
| 2021-01-08 | Fromen Peter Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +320,000 | 320,000 | ||
| 2021-01-08 | Van Oene Mark Chief Operating Officer | Grant or award | +335,000 | 335,000 |
Page 17 of 29 · 561 trades